A new consensus paper provides an updated evaluation of reference bone turnover markers (BTMs) and newer markers in the diagnosis and management of osteoporosis. The paper, titled "Update on the Role ...

Established antiresorptive treatments for osteoporosis only slow down bone loss, and available osteoanabolic therapies — although more effective — have broad limitations. Recent insights into ...

Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by persistent inflammation, which leads to joint damage and functional limitations 1. In addition to its impact on the joints, ...

The risk of fragility fractures is increased in people with both type 1 and type 2 diabetes. While guidance for the evaluation and management of fracture risk in these patients has been recently ...

CHICAGO — Two bone turnover markers were significantly lower at 3 months and 1 year in postmenopausal women who received estetrol (E4) compared with patients who received placebo, according to a study ...

Comparison of kidney cancer symptoms and quality of life (QoL) in renal cell cancer (RCC) patients (pts) receiving sorafenib vs interferon-α (IFN) ...

Researchers have found that proteins and pathways involved in inflammation are associated with changes in bone mineral density (BMD) over time. The research, could potentially lead to the ...

A new study published in The Journal of Nutrition shows daily consumption of prunes may reduce inflammation markers connected to bone signaling pathways and reduce the effects of bone loss among ...

SEATTLE — Among bariatric surgery patients treated with denosumab to counter bone loss, follow-up treatment with zoledronic acid prevented the rebound effect on markers of bone turnover that is ...